TORONTO, April 8, 2022 /CNW/ - Horizons ETFs
Management (Canada) Inc.
("Horizons ETFs") has completed the quarterly rebalances of
the holdings of the Horizons Marijuana Life Sciences Index ETF
(TSX: HMMJ) and the Horizons US Marijuana Index ETF (NEO:
HMUS).
HMMJ REBALANCE
HMMJ is the world's first ETF to offer direct exposure to North
American-listed securities having significant business activities
in the marijuana industry. This quarter, two companies were added
to the North American Marijuana Index (the "HMMJ Index") and
the HMMJ portfolio:
Additions
Company
Name
|
Ticker
|
Exchange
|
Leafly Holdings
Inc.
|
LFLY
|
NASDAQ
|
Urban-Gro
Inc.
|
UGRO
|
NASDAQ
|
HMMJ is an index (or passively managed) ETF, which seeks to
replicate, to the extent possible, the performance of the HMMJ
Index, net of expenses. The HMMJ Index, which rebalances quarterly,
has been designed to provide exposure to the performance of a
basket of North American publicly listed life sciences companies
with significant business activities in the marijuana industry. The
HMMJ Index selects from a current universe of companies that have
operations that may include one or more offerings of
biopharmaceuticals, medical manufacturing, distribution,
bio-products and other ancillary businesses related to the
marijuana industry.
"While the financial market performance has been mixed,
Canada's marijuana industry has
continued to solidify its position in our economy, having added
more than $43.5 billon to our
national GDP since legalization, according to
Deloitte," said Steve
Hawkins, President and CEO of Horizons ETFs. "At the same
time, Canada's licensed producers
are continuing to refine their operations, trim balance sheets,
strike deals and prepare themselves to take advantage of the next
big market opportunity on the horizon: federal legalization of
marijuana in the United
States."
The holdings of HMMJ and its current portfolio weights are
regularly updated and available at
https://www.HorizonsETFs.com/HMMJ. It is important to note that
HMMJ may not hold all of the constituents of the HMMJ Index.
Horizons ETFs, through the use of a stratified sampling strategy,
may invest in securities that closely match the investment
characteristics of the HMMJ Index, provided they are consistent
with HMMJ's investment objectives and strategies.
Performance Update as at March 31,
2022*
|
1
Month
|
3
Month
|
6
Month
|
YTD
|
1
Year
|
3
Year
|
Annualized
Since
Inception**
|
HMMJ
|
6.22%
|
-9.40%
|
-25.69%
|
-9.40%
|
-52.95%
|
-32.11%
|
-5.63%
|
*Source: Bloomberg,
as at March 31, 2022. **Since HMMJ's inception on April 4,
2017.
|
HMUS REBALANCE
HMUS is the world's first U.S.-focused marijuana index ETF. HMUS
seeks to replicate, to the extent possible, the
performance of the US Marijuana Companies Index (the "HMUS
Index"), net of expenses. The HMUS Index, which
rebalances quarterly, has been designed to
provide exposure to the performance of a basket of
North American publicly-listed life sciences companies with
significant business activities in, or significant
exposure to, the marijuana or hemp industries in the United States. Constituents of
the HMUS Index are selected from Canadian and U.S. exchanges.
This rebalance of the HMUS Index resulted in two companies being
added to the HMUS Index and the HMUS portfolio:
Additions
Company
Name
|
Ticker
|
Exchange
|
TPCO Holding
Corp.
|
GRAM/U
|
NEO
|
Tuatara Capital
Acquisition L.P.
|
TCAC
|
NASDAQ
|
"Cannabis reform in the United
States has been slow to materialize," said Mr. Hawkins.
"However, the most recent passage of the MORE Act in Congress
highlights that there is still significant political will and
opportunity to decriminalize marijuana on the federal level and
create the conditions necessary for legalization, which could
benefit U.S. multi-state operators to get access to key financial
services and build national infrastructure."
The holdings of HMUS and its current portfolio weights are
regularly updated and available at
https://www.HorizonsETFs.com/HMUS. HMUS may not hold all of the
constituents of the HMUS Index. Horizons ETFs, through the use of a
stratified sampling strategy, may invest in securities that closely
match the investment characteristics of the HMUS Index, provided
they are consistent with HMUS' investment objectives and
strategies.
Performance Update as at March 31,
2022*
|
1
Month
|
3
Month
|
6
Month
|
YTD
|
1
Year
|
Annualized
Since
Inception**
|
HMUS
|
-3.62%
|
-12.91%
|
-32.77%
|
-12.91%
|
-51.91%
|
-28.00%
|
*
|
Source: Bloomberg, as
at March 31, 2022. **Since HMUS' inception on April 17,
2019.
|
About Horizons ETFs Management (Canada) Inc. (www.HorizonsETFs.com)
Horizons ETFs Management (Canada) Inc. is an innovative financial
services company and offers one of the largest suites of exchange
traded funds in Canada. The
Horizons ETFs product family includes a broadly diversified range
of solutions for investors of all experience levels to meet their
investment objectives in a variety of market conditions. Horizons
ETFs has over $23 billion of assets
under management and 105 ETFs listed on major Canadian stock
exchanges.
Commissions, management fees and expenses all may be
associated with an investment in Horizons US Marijuana Index ETF
and the Horizons Marijuana Life Sciences Index ETF (the
"ETFs") managed by Horizons ETFs Management (Canada) Inc. The ETFs are not guaranteed,
their values change frequently and past performance may not be
repeated. The prospectus contains important detailed information
about the ETFs. Please read the prospectus before
investing.
*The indicated rates of return for HMMJ and HMUS are the
historical annual compounded total returns, including changes in
unit value and reinvestment of all distributions and do not take
into account sales, redemption, distribution or optional charges or
income taxes payable by any security holder that would have reduced
returns. The ETFs are not guaranteed, their values change
frequently, and past performance may not be repeated. Only the
returns for periods of one year or greater are annualized
returns.
HMMJ will not knowingly invest in any constituent issuers
that have exposure to the medical or recreational marijuana market
in the United States, unless or
until it becomes legal. HMMJ will not be directly engaged in the
manufacture, possession, use, sale or distribution of marijuana in
either Canada or the U.S.
Please read the full risk disclosure in the prospectus before
investing.
There are risks associated with this product. HMUS is
expected to invest in the Marijuana industry in certain U.S. states
that have legalized marijuana for therapeutic or adult-use, which
is currently illegal under U.S. federal law. HMUS will passively
invest in companies involved in the marijuana industry in the U.S.
where local state law regulates and permits such activities, as
well as in companies involved in the Canadian legal Marijuana
industry. HMUS will not be directly engaged in the manufacture,
importation, possession, use, sale or distribution of marijuana in
either Canada or the U.S.
Please read the full risk disclosure in the prospectus before
investing.
Certain statements may constitute a forward-looking
statement, including those identified by the expression "expect"
and similar expressions (including grammatical variations thereof).
The forward-looking statements are not historical facts but reflect
the author's current expectations regarding future results or
events. These forward-looking statements are subject to a number of
risks and uncertainties that could cause actual results or events
to differ materially from current expectations. These and other
factors should be considered carefully and readers should not place
undue reliance on such forward looking statements. These
forward-looking statements are made as of the date hereof and the
authors do not undertake to update any forward-looking statement
that is contained herein, whether as a result of new information,
future events or otherwise, unless required by applicable
law.
SOURCE Horizons ETFs Management (Canada) Inc.